Scientech Research »

Intensity Therapeutics shares owned by Scientech Research

Quarter-by-quarter ownership of Intensity Therapeutics (INTS) shares owned by Scientech Research from 13F filings

Historical chart of Scientech Research investment in Intensity Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intensity Therapeutics held by Scientech Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intensity Therapeutics by Scientech Research

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.0k 25k 0.24

More positions owned by Scientech Research

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Applovin Corp Com Cl A (APP)
Eli Lilly & Co. (LLY)
Regeneron Pharmaceuticals (REGN)
Alnylam Pharmaceuticals (ALNY)
Tilray (TLRY)
Uniqure Nv SHS (QURE)
Mongodb Cl A (MDB)
Insulet Corporation (PODD)
Transocean Registered Shs (RIG)
Zebra Technologies Corporati Cl A (ZBRA)
Robinhood Mkts Com Cl A (HOOD)
Graniteshares Etf Tr 2x Long Nvda Dai (NVDL)
Adobe Systems Incorporated (ADBE)

View all positions for Scientech Research

Top funds holding Intensity Therapeutics

Sapient Capital
Sentinus
Geode Capital Management
Vanguard Group
Mesirow Financial Investment Management International Equity
UBS Group
Brown Advisory Holdings Incorporated
Sigma Planning
Warberg Asset Management
Stonebridge Financial Group
IHT Wealth Management
William Blair $ Company
One Charles Private Wealth Services
Virtu Financial
Scientech Research

View all funds holding Intensity Therapeutics